1500mg per Week Testosterone – What Happened After 6 Months? Clinical Case Analysis

Member Access Required

Already a member? Sign In

Timeline

00:00

The case opens by describing six months of extremely high weekly testosterone use. Motivation is framed around strength and size, followed by a decline in wellbeing.

04:42

Medication and dosing details are reviewed, including large injections and intermittent estrogen suppression. Reported symptoms include fatigue, anxiety, and worsening erectile dysfunction over time.

07:46

Past history and social context are summarized to frame baseline risk and resilience. Common diagnoses and routine medicines are listed alongside lifestyle factors and stressors.

11:14

Vital signs and exam findings highlight hypertension, tachycardia, and visible facial swelling. The segment emphasizes that these findings can signal cardiovascular strain during escalation.

14:20

Cardiac imaging is discussed with a very high coronary calcium score in a key artery. Further testing is described as showing left ventricular hypertrophy on standard studies.

18:20

Lipid and chemistry results are reviewed with severely low HDL and elevated LDL values. Kidney markers are discussed cautiously because muscular build can distort creatinine interpretation.

20:57

Blood count and iron studies are emphasized, with high hemoglobin and hematocrit described clearly. Elevated iron saturation is noted as a concern for long term organ deposition risk.

23:45

A three door management framework is described, prioritizing stopping the extreme dose first. Medical support options are discussed as a bridge toward stabilization and safer maintenance.

26:05

The plan closes with transition to a supervised lower testosterone regimen plus cardiometabolic protection. Referrals and medications are framed as essential to reduce risk and improve symptoms.

Video Summary

A thirty four year old man reports using very high weekly testosterone for months. The dosing pattern is described as repeated large injections several times each week. New concerns include fatigue, anxiety, and erectile dysfunction that worsened over time. A review of history notes common problems such as asthma, reflux, and mild depression. Lifestyle details include occasional cannabis gummies and social alcohol use without dependence. The presentation highlights how symptoms can appear after an early period of feeling great. A goal of staying big and strong is described as the motivation for continued escalation.

Vital signs show significant hypertension and a fast resting heart rate at evaluation. Physical findings include facial puffiness and visible redness suggestive of volume and pressure strain. A coronary calcium scan is discussed with a very high score concentrated in a major artery. Cardiac testing is described as showing left ventricular hypertrophy on electrocardiogram and echocardiography. Laboratory review describes severely low HDL cholesterol and an elevated LDL cholesterol level. Kidney markers are described as borderline on creatinine with uncertainty from high muscle mass. The case emphasizes that multiple systems can be stressed simultaneously during extreme androgen exposure.

Blood testing shows markedly elevated hemoglobin and hematocrit consistent with androgen driven erythrocytosis. Iron studies are described as elevated, raising concern for iron overload and deposition risk. Hormone testing is noted as above assay limits for total testosterone with high estradiol measurements. An aromatase inhibitor schedule is described, but the plan shifts away from that approach. The management plan includes stopping the extreme dose and transitioning to a supervised lower regimen. Cardiology and lipid management are emphasized, including blood pressure control and aggressive LDL reduction. Follow up guidance stresses gradual stabilization, monitoring symptoms, and coordinated specialist care.

Drug Callouts

Testosterone

Testosterone is the primary androgen hormone used medically for confirmed deficiency states. The case centers on extreme weekly dosing followed by transition to a lower supervised regimen.

Sustanon

Sustanon is a testosterone ester blend used by injection to deliver testosterone over time. The dosing schedule describes repeated large injections contributing to very high hormone exposure.

Anastrozole

Anastrozole is an aromatase inhibitor that reduces conversion of testosterone into estradiol. It is described as taken intermittently when gynecomastia and estrogen symptoms appeared.

Human chorionic gonadotropin

Human chorionic gonadotropin is a hormone drug that can stimulate testicular testosterone production. It is used in the plan as a supportive medicine while fertility goals are discussed.

Clomiphene

Clomiphene is a selective estrogen receptor modulator used to stimulate gonadotropin release. It is discussed as an additional option during medical grade recovery support planning.

Losartan

Losartan is an angiotensin receptor blocker used to treat hypertension and protect organs. It is started to improve blood pressure control during the risk reduction strategy.

Rosuvastatin

Rosuvastatin is a statin drug that lowers LDL cholesterol and reduces cardiovascular risk. An every other day regimen is described as part of aggressive lipid management.

Evolocumab

Evolocumab is a PCSK9 inhibitor injection used to lower LDL cholesterol substantially. It is added to rapidly reduce LDL burden given severe coronary calcification concerns.

Icosapent ethyl

Icosapent ethyl is a purified EPA medication used to reduce triglycerides and cardiovascular risk. It is included as an adjunct therapy within the cardiometabolic protection plan.

Sertraline

Sertraline is a selective serotonin reuptake inhibitor used to treat depression and anxiety disorders. The patient history notes intermittent use with perceived sexual side effects.

Condition Callouts

Hypertension

Hypertension is persistently elevated blood pressure that increases heart and kidney strain. The case reports a reading around one hundred fifty over ninety four during evaluation.

Hyperlipidemia

Hyperlipidemia is abnormal blood lipid levels that raise atherosclerotic cardiovascular risk. The case notes elevated LDL and very low HDL values during laboratory review.

Left ventricular hypertrophy

Left ventricular hypertrophy is thickening of the heart’s main pumping chamber muscle over time. Both electrocardiogram and echocardiography are described as showing this pattern.

Coronary artery disease

Coronary artery disease is plaque buildup in coronary arteries that can cause heart attacks. A very high calcium score concentrated in a major artery is described as alarming.

Erectile dysfunction

Erectile dysfunction is persistent difficulty achieving or maintaining erections adequate for sexual activity. The chief complaint includes severe erectile dysfunction after months of escalation.

Gynecomastia

Gynecomastia is benign enlargement of male breast tissue related to hormonal imbalance. Breast symptoms are referenced when describing intermittent use of estrogen suppression medication.

Androgen-induced erythrocytosis

Androgen-induced erythrocytosis is increased red blood cell production triggered by androgen exposure. Markedly elevated hemoglobin and hematocrit values are emphasized as a major danger.

Sleep apnea

Sleep apnea is repeated breathing interruption during sleep that can worsen blood pressure and oxygenation. Possible contribution is discussed when explaining why blood markers can worsen.

Depression

Depression is a mood disorder characterized by persistent low mood and reduced interest. Mild depression history is noted, with anxiety symptoms worsening during extreme dosing.

Gastroesophageal reflux disease

Gastroesophageal reflux disease is reflux of stomach contents causing heartburn and irritation. Heartburn history is described along with use of acid reducing medication.

Key Takeaways

Extremely high weekly testosterone dosing was linked with fatigue and erectile dysfunction.
Hypertension and tachycardia were documented and treated as urgent risk signals.
A very high coronary calcium score prompted aggressive cardiology evaluation.
Hemoglobin, hematocrit, and iron saturation were elevated, raising deposition concerns.
Transitioning to supervised lower dosing plus lipid therapy was emphasized for safety.